The stem cell niche provides a regulatory microenvironment for cells as diverse as totipotent embryonic stem cells to cancer stem cells (CSCs) which exhibit stem cell-like characteristics and have the capability of regenerating the bulk of tumor cells while maintaining self-renewal potential. The transmembrane glycoprotein CD44 is a common component of the stem cell niche and exists as a standard isoform (CD44s) and a range of variant isoforms (CD44v) generated though alternative splicing. CD44 modulates signal transduction through post-translational modifications as well as interactions with hyaluronan, extracellular matrix molecules and growth factors and their cognate receptor tyrosine kinases. While the function of CD44 in hematopoietic stem cells has been studied in considerable detail, our knowledge of CD44 function in tissue-derived stem cell niches remains limited. Here we review CD44s and CD44v in both hematopoietic and tissue-derived stem cell niches, focusing on their roles in regulating stem cell behavior including self-renewal and differentiation in addition to cell-matrix interactions and signal transduction during cell migration and tumor progression. Determining the role of CD44 and CD44v in normal stem cell, CSC and (pre)metastatic niches and elucidating their unique functions could provide tools and therapeutic strategies for treating diseases as diverse as fibrosis during injury repair to cancer progression.
GallatinWM, WeissmanIL, ButcherEC. A cell-surface molecule involved in organ-specific homing of lymphocytes. Nature1983; 304: 30–4
2.
GoldsteinLA, ZhouDF, PickerLJ, MintyCN, BargatzeRF, DingJF, ButcherEC. A human lymphocyte homing receptor, the hermes antigen, is related to cartilage proteoglycan core and link proteins. Cell1989; 56: 1063–72
3.
HaegelH, DierichA, CeredigR. CD44 in differentiated embryonic stem cells: surface expression and transcripts encoding multiple variants. Dev Immunol1994; 3: 239–46
CampagnoliC, RobertsIA, KumarS, BennettPR, BellantuonoI, FiskNM. Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood2001; 98: 2396–402
6.
DuL, WangH, HeL, ZhangJ, NiB, WangX, JinH, CahuzacN, MehrpourM, LuY, ChenQ. CD44 is of functional importance for colorectal cancer stem cells. Clin Cancer Res2008; 14: 6751–60
7.
DalerbaP, DyllaSJ, ParkIK, LiuR, WangX, ChoRW, HoeyT, GurneyA, HuangEH, SimeoneDM, SheltonAA, ParmianiG, CastelliC, ClarkeMF. Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci USA2007; 104: 10158–63
8.
Al-HajjM, WichaMS, Benito-HernandezA, MorrisonSJ, ClarkeMF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA2003; 100: 3983–8
9.
PontiD, CostaA, ZaffaroniN, PratesiG, PetrangoliniG, CoradiniD, PilottiS, PierottiMA, DaidoneMG. Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res2005; 65: 5506–11
10.
LiC, HeidtDG, DalerbaP, BurantCF, ZhangL, AdsayV, WichaM, ClarkeMF, SimeoneDM. Identification of pancreatic cancer stem cells. Cancer Res2007; 67: 1030–7
11.
LiC, LeeCJ, SimeoneDM. Identification of human pancreatic cancer stem cells. Methods Mol Biol2009; 568: 161–73
12.
PrinceME, SivanandanR, KaczorowskiA, WolfGT, KaplanMJ, DalerbaP, WeissmanIL, ClarkeMF, AillesLE. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci USA2007; 104: 973–8
13.
CollinsAT, BerryPA, HydeC, StowerMJ, MaitlandNJ. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res2005; 65: 10946–51
14.
PatrawalaL, CalhounT, Schneider-BroussardR, LiH, BhatiaB, TangS, ReillyJG, ChandraD, ZhouJ, ClaypoolK, CoghlanL, TangDG. Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells. Oncogene2006; 25: 1696–708
15.
RybakAP, HeL, KapoorA, CutzJC, TangD. Characterization of sphere-propagating cells with stem-like properties from DU145 prostate cancer cells. Biochim Biophys Acta2011; 1813: 683–94
16.
ShackletonM, VaillantF, SimpsonKJ, StinglJ, SmythGK, Asselin-LabatML, WuL, LindemanGJ, VisvaderJE. Generation of a functional mammary gland from a single stem cell. Nature2006; 439: 84–8
17.
LeongKG, WangBE, JohnsonL, GaoWQ. Generation of a prostate from a single adult stem cell. Nature2008; 456: 804–8
18.
GuG, YuanJ, WillsM, KasperS. Prostate cancer cells with stem cell characteristics reconstitute the original human tumor in vivo. Cancer Res2007; 67: 4807–15
PhamPV, PhanNL, NguyenNT, TruongNH, DuongTT, LeDV, TruongKD, PhanNK. Differentiation of breast cancer stem cells by knockdown of CD44: promising differentiation therapy. J Transl Med2011; 9: 209
21.
TirinoV, DesiderioV, d'AquinoR, De FrancescoF, PirozziG, GrazianoA, GalderisiU, CavaliereC, De RosaA, PapaccioG, GiordanoA. Detection and characterization of CD133+ cancer stem cells in human solid tumours. PLoS One2008; 3: e3469
22.
OlakuV, MatzkeA, MitchellC, HasenauerS, SakkaravarthiA, PaceG, PontaH, Orian-RousseauV. c-Met recruits ICAM-1 as a coreceptor to compensate for the loss of CD44 in Cd44 null mice. Mol Biol Cell2011; 22: 2777–86
23.
ProtinU, SchweighofferT, JochumW, HilbergF. CD44-deficient mice develop normally with changes in subpopulations and recirculation of lymphocyte subsets. J Immunol1999; 163: 4917–23
24.
YuWH, WoessnerJFJr, McNeishJD, StamenkovicI. CD44 anchors the assembly of matrilysin/MMP-7 with heparin-binding epidermal growth factor precursor and ErbB4 and regulates female reproductive organ remodeling. Genes Dev2002; 16: 307–23
25.
KayaG, RodriguezI, JorcanoJL, VassalliP, StamenkovicI. Selective suppression of CD44 in keratinocytes of mice bearing an antisense CD44 transgene driven by a tissue-specific promoter disrupts hyaluronate metabolism in the skin and impairs keratinocyte proliferation. Genes Dev1997; 11: 996–1007
26.
PontaH, ShermanL, HerrlichPA. CD44: from adhesion molecules to signalling regulators. Nat Rev Mol Cell Biol2003; 4: 33–45
27.
JiangD, LiangJ, NoblePW. Hyaluronan as an immune regulator in human diseases. Physiol Rev2011; 91: 221–64
SacksteinR. Glycosyltransferase-programmed stereosubstitution (GPS) to create HCELL: engineering a roadmap for cell migration. Immunol Rev2009; 230: 51–74
30.
TurleyEA, NaorD. RHAMM and CD44 peptides-analytic tools and potential drugs. Front Biosci2012; 17: 1775–94
31.
StamenkovicI, AmiotM, PesandoJM, SeedB. A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link protein family. Cell1989; 56: 1057–62
32.
ScreatonGR, BellMV, BellJI, JacksonDG. The identification of a new alternative exon with highly restricted tissue expression in transcripts encoding the mouse Pgp-1 (CD44) homing receptor. Comparison of all 10 variable exons between mouse, human, and rat. J Biol Chem1993; 268: 12235–38
33.
ScreatonGR, BellMV, JacksonDG, CornelisFB, GerthU, BellJI. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci USA1992; 89: 12160–64
34.
YangB, YangBL, SavaniRC, TurleyEA. Identification of a common hyaluronan binding motif in the hyaluronan binding proteins RHAMM, CD44 and link protein. Embo J1994; 13: 286–96
35.
TerieteP, BanerjiS, NobleM, BlundellCD, WrightAJ, PickfordAR, LoweE, MahoneyDJ, TammiMI, KahmannJD, CampbellID, DayAJ, JacksonDG. Structure of the regulatory hyaluronan binding domain in the inflammatory leukocyte homing receptor CD44. Mol Cell2004; 13: 483–96
36.
BanerjiS, DayAJ, KahmannJD, JacksonDG. Characterization of a functional hyaluronan-binding domain from the human CD44 molecule expressed in Escherichia coli. Protein Exp Purif1998; 14: 371–81
37.
DayAJ, PrestwichGD. Hyaluronan-binding proteins: tying up the giant. J Biol Chem2002; 277: 4585–8
38.
DayAJ, SheehanJK. Hyaluronan: polysaccharide chaos to protein organisation. Curr Opin Struct Biol2001; 11: 617–22
39.
RodgersAK, NairA, BinkleyPA, TekmalR, SchenkenRS. Inhibition of CD44 N- and O-linked glycosylation decreases endometrial cell lines attachment to peritoneal mesothelial cells. Fertil Steril2011; 95: 823–5
40.
OkamotoI, KawanoY, TsuikiH, SasakiJ, NakaoM, MatsumotoM, SugaM, AndoM, NakajimaM, SayaH. CD44 cleavage induced by a membrane-associated metalloprotease plays a critical role in tumor cell migration. Oncogene1999; 18: 1435–46
41.
ZöllerM. CD44: can a cancer-initiating cell profit from an abundantly expressed molecule?Nat Rev Cancer2011; 11: 254–67
42.
BourguignonLY. Hyaluronan-mediated CD44 activation of RhoGTPase signaling and cytoskeleton function promotes tumor progression. Semin Cancer Biol2008; 18: 251–9
NaganoO, MurakamiD, HartmannD, De StrooperB, SaftigP, IwatsuboT, NakajimaM, ShinoharaM, SayaH. Cell-matrix interaction via CD44 is independently regulated by different metalloproteinases activated in response to extracellular Ca(2+) influx and PKC activation. J Cell Biol2004; 165: 893–902
45.
NakamuraH, SuenagaN, TaniwakiK, MatsukiH, YonezawaK, FujiiM, OkadaY, SeikiM. Constitutive and induced CD44 shedding by ADAM-like proteases and membrane-type 1 matrix metalloproteinase. Cancer Res2004; 64: 876–82
YuQ, TooleBP, StamenkovicI. Induction of apoptosis of metastatic mammary carcinoma cells in vivo by disruption of tumor cell surface CD44 function. J Exp Med1997; 186: 1985–96
48.
SyMS, GuoYJ, StamenkovicI. Inhibition of tumor growth in vivo with a soluble CD44-immunoglobulin fusion protein. J Exp Med1992; 176: 623–7
49.
ChiuRK, CarpenitoC, DoughertyST, HayesGM, DoughertyGJ. Identification and characterization of CD44RC, a novel alternatively spliced soluble CD44 isoform that can potentiate the hyaluronan binding activity of cell surface CD44. Neoplasia1999; 1: 446–52
50.
LiuD, SyMS. Phorbol myristate acetate stimulates the dimerization of CD44 involving a cysteine in the transmembrane domain. J Immunol1997; 159: 2702–11
51.
ThorneRF, LeggJW, IsackeCM. The role of the CD44 transmembrane and cytoplasmic domains in co-ordinating adhesive and signalling events. J Cell Sci2004; 117: 373–80
52.
BrownMS, YeJ, RawsonRB, GoldsteinJL. Regulated intramembrane proteolysis: a control mechanism conserved from bacteria to humans. Cell2000; 100: 391–8
53.
NeameSJ, UffCR, SheikhH, WheatleySC, IsackeCM. CD44 exhibits a cell type dependent interaction with triton X-100 insoluble, lipid rich, plasma membrane domains. J Cell Sci1995; 108(Pt 9):3127–35
54.
PerschlA, LesleyJ, EnglishN, HymanR, TrowbridgeIS. Transmembrane domain of CD44 is required for its detergent insolubility in fibroblasts. J Cell Sci1995; 108(Part 3):1033–41
55.
KoradeZ, KenworthyAK. Lipid rafts, cholesterol, and the brain. Neuropharmacology2008; 55: 1265–73
56.
LeggJW, IsackeCM. Identification and functional analysis of the ezrin-binding site in the hyaluronan receptor, CD44. Curr Biol1998; 8: 705–8
57.
LokeshwarVB, BourguignonLY. Tyrosine phosphatase activity of lymphoma CD45 (GP180) is regulated by a direct interaction with the cytoskeleton. J Biol Chem1992; 267: 21551–57
58.
BourguignonLY, GiladE, BrightmanA, DiedrichF, SingletonP. Hyaluronan-CD44 interaction with leukemia-associated RhoGEF and epidermal growth factor receptor promotes Rho/Ras co-activation, phospholipase C epsilon-Ca2+ signaling, and cytoskeleton modification in head and neck squamous cell carcinoma cells. J Biol Chem2006; 281: 14026–40
59.
BuckleyST, MedinaC, KasperM, EhrhardtC. Interplay between RAGE, CD44, and focal adhesion molecules in epithelial-mesenchymal transition of alveolar epithelial cells. Am J Physiol Lung Cell Mol Physiol2011; 300: L548–559
60.
ChoSH, ParkYS, KimHJ, KimCH, LimSW, HuhJW, LeeJH, KimHR. CD44 enhances the epithelial-mesenchymal transition in association with colon cancer invasion. Int J Oncol2012; 41: 211–8
OkamotoI, KawanoY, MatsumotoM, SugaM, KaibuchiK, AndoM, SayaH. Regulated CD44 cleavage under the control of protein kinase C, calcium influx, and the Rho family of small G proteins. J Biol Chem1999; 274: 25525–34
64.
LeeJL, WangMJ, ChenJY. Acetylation and activation of STAT3 mediated by nuclear translocation of CD44. J Cell Biol2009; 185: 949–57
65.
MatteucciE, BendinelliP, DesiderioMA. Nuclear localization of active HGF receptor Met in aggressive MDA-MB231 breast carcinoma cells. Carcinogenesis2009; 30: 937–45
66.
OkamotoI, KawanoY, MurakamiD, SasayamaT, ArakiN, MikiT, WongAJ, SayaH. Proteolytic release of CD44 intracellular domain and its role in the CD44 signaling pathway. J Cell Biol2001; 155: 755–62
67.
De FalcoV, TamburrinoA, VentreS, CastelloneMD, MalekM, ManieSN, SantoroM. CD44 proteolysis increases CREB phosphorylation and sustains proliferation of thyroid cancer cells. Cancer Res2012; 72: 1449–58
68.
NaganoO, SayaH. Mechanism and biological significance of CD44 cleavage. Cancer Sci2004; 95: 930–5
69.
TakahashiN, KnudsonCB, ThankamonyS, AriyoshiW, MellorL, ImHJ, KnudsonW. Induction of CD44 cleavage in articular chondrocytes. Arthritis Rheum2011; 62: 1338–48
70.
JaniszewskaM, De VitoC, Le BitouxMA, FuscoC, StamenkovicI. Transportin regulates nuclear import of CD44. J Biol Chem2010; 285: 30548–57
71.
PerschlA, LesleyJ, EnglishN, TrowbridgeI, HymanR. Role of Cd44 cytoplasmic domain in hyaluronan-binding. Eur J Immunol1995; 25: 495–501
72.
GoldsteinLA, ButcherEC. Identification of mRNA that encodes an alternative form of H-CAM(CD44) in lymphoid and nonlymphoid tissues. Immunogenetics1990; 32: 389–97
73.
JiangH, KnudsonCB, KnudsonW. Antisense inhibition of CD44 tailless splice variant in human articular chondrocytes promotes hyaluronan internalization. Arthritis Rheum2001; 44: 2599–610
74.
KunejT, GodnicI, HorvatS, ZorcM, CalinGA. Cross talk between microRNA and coding cancer genes. Cancer J2012; 18: 223–31
75.
YangK, HandoreanAM, IczkowskiKA. MicroRNAs 373 and 520c are downregulated in prostate cancer, suppress CD44 translation and enhance invasion of prostate cancer cells in vitro. Int J Clin Exp Pathol2009; 2: 361–9
76.
ChengW, LiuT, WanX, GaoY, WangH. MicroRNA-199a targets CD44 to suppress the tumorigenicity and multidrug resistance of ovarian cancer-initiating cells. FEBS J2012; 279: 2047–59
77.
RutnamZJ, YangBB. The non-coding 3’ UTR of CD44 induces metastasis by regulating extracellular matrix functions. J Cell Sci2012; 125: 2075–85
78.
ScaddenDT. The stem-cell niche as an entity of action. Nature2006; 441: 1075–9
79.
OhlsteinB, SpradlingA. The adult Drosophila posterior midgut is maintained by pluripotent stem cells. Nature2006; 439: 470–4
VoogJ, D'AlterioC, JonesDL. Multipotent somatic stem cells contribute to the stem cell niche in the Drosophila testis. Nature2008; 454: 1132–6
82.
SatoT, van EsJH, SnippertHJ, StangeDE, VriesRG, van den BornM, BarkerN, ShroyerNF, van de WeteringM, CleversH. Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts. Nature2011; 469: 415–8
83.
PrestonM, ShermanLS. Neural stem cell niches: roles for the hyaluronan-based extracellular matrix. Front Biosci (Schol Ed)2011; 3: 1165–79
84.
SolisMA, ChenY-H, WongTY, BittencourtVZ, LinY-C, HuangLLH. Hyaluronan regulates cell behavior: a potential niche matrix for stem cells. Biochem Res Int2012;in press
85.
ShuklaS, NairR, RolleMW, BraunKR, ChanCK, JohnsonPY, WightTN, McDevittTC. Synthesis and organization of hyaluronan and versican by embryonic stem cells undergoing embryoid body differentiation. J Histochem Cytochem2010; 58: 345–58
86.
SchraufstatterIU, SerobyanN, LoringJ, KhaldoyanidiSK. Hyaluronan is required for generation of hematopoietic cells during differentiation of human embryonic stem cells. J Stem Cells2010; 5: 9–21
87.
GrskovicB, PollaschekC, MuellerMM, StuhlmeierKM. Expression of hyaluronan synthase genes in umbilical cord blood stem/progenitor cells. Biochim Biophys Acta2006; 1760: 890–5
88.
KimJ, KimIS, ChoTH, KimHC, YoonSJ, ChoiJ, ParkY, SunK, HwangSJ. In vivo evaluation of MMP sensitive high-molecular weight HA-based hydrogels for bone tissue engineering. J Biomed Mater Res A2010; 95: 673–81
GerechtS, BurdickJA, FerreiraLS, TownsendSA, LangerR, Vunjak-NovakovicG. Hyaluronic acid hydrogel for controlled self-renewal and differentiation of human embryonic stem cells. Proc Natl Acad Sci USA2007; 104: 11298–303
91.
HamannKJ, DowlingTL, NeeleySP, GrantJA, LeffAR. Hyaluronic acid enhances cell proliferation during eosinopoiesis through the CD44 surface antigen. J Immunol1995; 154: 4073–80
92.
DelfinoDV, PatreneKD, DeLeoAB, DeLeoR, HerbermanRB, BoggsSS. Role of CD44 in the development of natural killer cells from precursors in long-term cultures of mouse bone marrow. J Immunol1994; 152: 5171–9
93.
MarquezC, TriguerosC, FernandezE, ToribioML. The development of T and non-T cell lineages from CD34+ human thymic precursors can be traced by the differential expression of CD44. J Exp Med1995; 181: 475–83
94.
MaharjanAS, PillingD, GomerRH. High and low molecular weight hyaluronic acid differentially regulate human fibrocyte differentiation. PLoS One2011; 6: e26078
95.
HerrlichP, MorrisonH, SleemanJ, Orian-RousseauV, KonigH, Weg-RemersS, PontaH. CD44 acts both as a growth- and invasiveness-promoting molecule and as a tumor-suppressing cofactor. Ann NY Acad Sci2000; 910: 106–18; discussion 118-120
96.
SacksteinR. The biology of CD44 and HCELL in hematopoiesis: the ‘step 2-bypass pathway’ and other emerging perspectives. Curr Opin Hematol2011; 18: 239–48
97.
ZhuH, MitsuhashiN, KleinA, BarskyLW, WeinbergK, BarrML, DemetriouA, WuGD. The role of the hyaluronan receptor CD44 in mesenchymal stem cell migration in the extracellular matrix. Stem Cells2006; 24: 928–35
98.
AvigdorA, GoichbergP, ShivtielS, DarA, PeledA, SamiraS, KolletO, HershkovizR, AlonR, HardanI, Ben-HurH, NaorD, NaglerA, LapidotT. CD44 and hyaluronic acid cooperate with SDF-1 in the trafficking of human CD34+ stem/progenitor cells to bone marrow. Blood2004; 103: 2981–9
99.
SchwarzlerC, OliferenkoS, GunthertU.Variant isoforms of CD44 are required in early thymocyte development. Eur J Immunol2001; 31: 2997–3005
100.
ParekhA, WeaverAM. Regulation of cancer invasiveness by the physical extracellular matrix environment. Cell Adh Migr2009; 3: 288–92
101.
TaipaleJ, Keski-OjaJ. Growth factors in the extracellular matrix. FASEB J1997; 11: 51–9
102.
BernfieldM, GotteM, ParkPW, ReizesO, FitzgeraldML, LincecumJ, ZakoM. Functions of cell surface heparan sulfate proteoglycans. Annu Rev Biochem1999; 68: 729–77
103.
van der VoortR, TaherTE, WielengaVJ, SpaargarenM, PrevoR, SmitL, DavidG, HartmannG, GherardiE, PalsST. Heparan sulfate-modified CD44 promotes hepatocyte growth factor/scatter factor-induced signal transduction through the receptor tyrosine kinase c-Met. J Biol Chem1999; 274: 6499–506
104.
GrimmeHU, TermeerCC, BennettKL, WeissJM, SchopfE, AruffoA, SimonJC. Colocalization of basic fibroblast growth factor and CD44 isoforms containing the variably spliced exon v3 (CD44v3) in normal skin and in epidermal skin cancers. Br J Dermatol1999; 141: 824–32
105.
BennettKL, JacksonDG, SimonJC, TanczosE, PeachR, ModrellB, StamenkovicI, PlowmanG, AruffoA. CD44 isoforms containing exon V3 are responsible for the presentation of heparin-binding growth factor. J Cell Biol1995; 128: 687–98
106.
DelonI, BrownNH. Integrins and the actin cytoskeleton. Curr Opin Cell Biol2007; 19: 43–50
107.
ProwseAB, ChongF, GrayPP, MunroTP. Stem cell integrins: implications for ex-vivo culture and cellular therapies. Stem Cell Res2011; 6: 1–12
108.
MafiP, HindochaS, MafiR, GriffinM, KhanWS. Adult mesenchymal stem cells and cell surface characterization - a systematic review of the literature. Open Orthop J2011; 5: 253–60
109.
SiegelmanMH, StanescuD, EstessP. The CD44-initiated pathway of T-cell extravasation uses VLA-4 but not LFA-1 for firm adhesion. J Clin Invest2000; 105: 683–91
110.
NandiA, EstessP, SiegelmanM. Bimolecular complex between rolling and firm adhesion receptors required for cell arrest; CD44 association with VLA-4 in T cell extravasation. Immunity2004; 20: 455–65
111.
Redondo-MunozJ, Ugarte-BerzalE, Garcia-MarcoJA, del CerroMH, Van den SteenPE, OpdenakkerG, TerolMJ, Garcia-PardoA. Alpha4beta1 integrin and 190-kDa CD44v constitute a cell surface docking complex for gelatinase B/MMP-9 in chronic leukemic but not in normal B cells. Blood2008; 112: 169–78
112.
SacksteinR. Glycoengineering of HCELL, the human bone marrow homing receptor: sweetly programming cell migration. Ann Biomed Eng2012; 40: 766–76
113.
ZarbockA, LeyK, McEverRP, HidalgoA. Leukocyte ligands for endothelial selectins: specialized glycoconjugates that mediate rolling and signaling under flow. Blood2011; 118: 6743–51
KnudsonW, BartnikE, KnudsonCB. Assembly of pericellular matrices by COS-7 cells transfected with CD44 lymphocyte-homing receptor genes. Proc Natl Acad Sci USA1993; 90: 4003–7
116.
JiangH, PetersonRS, WangW, BartnikE, KnudsonCB, KnudsonW. A requirement for the CD44 cytoplasmic domain for hyaluronan binding, pericellular matrix assembly, and receptor-mediated endocytosis in COS-7 cells. J Biol Chem2002; 277: 10531–38
117.
GoncharovaV, SerobyanN, IizukaS, SchraufstatterI, de RidderA, PovaliyT, WackerV, ItanoN, KimataK, OrlovskajaIA, YamaguchiY, KhaldoyanidiS. Hyaluronan expressed by the hematopoietic microenvironment is required for bone marrow hematopoiesis. J Biol Chem2012; 287: 25419–33
118.
ChoudharyM, ZhangX, StojkovicP, HyslopL, AnyfantisG, HerbertM, MurdochAP, StojkovicM, LakoM. Putative role of hyaluronan and its related genes, HAS2 and RHAMM, in human early preimplantation embryogenesis and embryonic stem cell characterization. Stem Cells2007; 25: 3045–57
119.
GirishKS, KemparajuK. The magic glue hyaluronan and its eraser hyaluronidase: a biological overview. Life Sci2007; 80: 1921–43
120.
KnudsonCB. Hyaluronan and CD44: strategic players for cell-matrix interactions during chondrogenesis and matrix assembly. Birth Defects Res C Embryo Today2003; 69: 174–96
121.
WangN, TytellJD, IngberDE. Mechanotransduction at a distance: mechanically coupling the extracellular matrix with the nucleus. Nat Rev Mol Cell Biol2009; 10: 75–82
122.
OkudaH, KobayashiA, XiaB, WatabeM, PaiSK, HirotaS, XingF, LiuW, PandeyPR, FukudaK, ModurV, GhoshA, WilberA, WatabeK. Hyaluronan synthase HAS2 promotes tumor progression in bone by stimulating the interaction of breast cancer stem-like cells with macrophages and stromal cells. Cancer Res2011; 72: 537–47
123.
Orian-RousseauV, ChenL, SleemanJP, HerrlichP, PontaH. CD44 is required for two consecutive steps in HGF/c-Met signaling. Genes Dev2002; 16: 3074–86
124.
RecioJA, MerlinoG. Hepatocyte growth factor/scatter factor induces feedback up-regulation of CD44v6 in melanoma cells through Egr-1. Cancer Res2003; 63: 1576–82
125.
SingletonPA, SalgiaR, Moreno-VinascoL, MoitraJ, SammaniS, MirzapoiazovaT, GarciaJG. CD44 regulates hepatocyte growth factor-mediated vascular integrity. Role of c-Met, Tiam1/Rac1, dynamin 2, and cortactin. J Biol Chem2007; 282: 30643–57
126.
BourguignonLY, SpevakCC, WongG, XiaW, GiladE. Hyaluronan-CD44 interaction with protein kinase C(epsilon) promotes oncogenic signaling by the stem cell marker Nanog and the Production of microRNA-21, leading to down-regulation of the tumor suppressor protein PDCD4, anti-apoptosis, and chemotherapy resistance in breast tumor cells. J Biol Chem2009; 284: 26533–46
127.
ThankamonySP, SacksteinR. Enforced hematopoietic cell E- and L-selectin ligand (HCELL) expression primes transendothelial migration of human mesenchymal stem cells. Proc Natl Acad Sci USA2011; 108: 2258–63
128.
ZöllerM, JungT.The Colorectal Cancer Initiating Cell: Markers and Their Role in Liver Metastasis. In: BrodtP, ed. Cancer Metastasis - Biology and Treatment. Vol. 16. New York: Springer Science & Business Media B.V.; 2011:98–127
129.
WielengaVJ, SmitsR, KorinekV, SmitL, KielmanM, FoddeR, CleversH, PalsST. Expression of CD44 in Apc and Tcf mutant mice implies regulation by the WNT pathway. Am J Pathol1999; 154: 515–23
130.
KlingbeilP, MarhabaR, JungT, KirmseR, LudwigT, ZöllerM. CD44 variant isoforms promote metastasis formation by a tumor cell-matrix cross-talk that supports adhesion and apoptosis resistance. Mol Cancer Res2009; 7: 168–79
131.
LiuD, TrojanowiczB, YeL, LiC, ZhangL, LiX, LiG, ZhengY, ChenL. The invasion and metastasis promotion role of CD97 small isoform in gastric carcinoma. PLoS One2012; 7: e39989
132.
RamirezMA, PericuestaE, Yanez-MoM, PalaszA, Gutierrez-AdanA. Effect of long-term culture of mouse embryonic stem cells under low oxygen concentration as well as on glycosaminoglycan hyaluronan on cell proliferation and differentiation. Cell Prolif2011; 44: 75–85
EliassonP, JonssonJI. The hematopoietic stem cell niche: low in oxygen but a nice place to be. J Cell Physiol2010; 222: 17–22
135.
ChowDC, WenningLA, MillerWM, PapoutsakisET. Modeling pO(2) distributions in the bone marrow hematopoietic compartment. II. Modified Kroghian models. Biophys J2001; 81: 685–96
136.
ParmarK, MauchP, VergilioJA, SacksteinR, DownJD. Distribution of hematopoietic stem cells in the bone marrow according to regional hypoxia. Proc Natl Acad Sci USA2007; 104: 5431–6
137.
De FilippisL, DeliaD. Hypoxia in the regulation of neural stem cells. Cell Mol Life Sci2011; 68: 2831–44
138.
RehnM, OlssonA, ReckzehK, DiffnerE, CarmelietP, LandbergG, CammengaJ. Hypoxic induction of vascular endothelial growth factor regulates murine hematopoietic stem cell function in the low-oxygenic niche. Blood2011; 118: 1534–43
139.
JingD, WobusM, PoitzDM, BornhauserM, EhningerG, OrdemannR. Oxygen tension plays a critical role in the hematopoietic microenvironment in vitro. Haematologica2011; 97: 331–9
MiharadaK, KarlssonG, RehnM, RorbyE, SivaK, CammengaJ, KarlssonS. Cripto regulates hematopoietic stem cells as a hypoxic-niche-related factor through cell surface receptor GRP78. Cell Stem Cell2011; 9: 330–44
142.
EzashiT, DasP, RobertsRM. Low O2 tensions and the prevention of differentiation of hES cells. Proc Natl Acad Sci USA2005; 102: 4783–8
143.
ChenHF, KuoHC, ChenW, WuFC, YangYS, HoHN. A reduced oxygen tension (5%) is not beneficial for maintaining human embryonic stem cells in the undifferentiated state with short splitting intervals. Hum Reprod2009; 24: 71–80
144.
ZhaoH, TanakaT, MitlitskiV, HeeterJ, BalazsEA, DarzynkiewiczZ. Protective effect of hyaluronate on oxidative DNA damage in WI-38 and A549 cells. Int J Oncol2008; 32: 1159–67
145.
ThankamonySP, KnudsonW. Acylation of CD44 and its association with lipid rafts are required for receptor and hyaluronan endocytosis. J Biol Chem2006; 281: 34601–09
146.
GrishkoV, XuM, HoR, MatesA, WatsonS, KimJT, WilsonGL, PearsallAWt.Effects of hyaluronic acid on mitochondrial function and mitochondria-driven apoptosis following oxidative stress in human chondrocytes. J Biol Chem2009; 284: 9132–9
147.
IshimotoT, NaganoO, YaeT, TamadaM, MotoharaT, OshimaH, OshimaM, IkedaT, AsabaR, YagiH, MasukoT, ShimizuT, IshikawaT, KaiK, TakahashiE, ImamuraY, BabaY, OhmuraM, SuematsuM, BabaH, SayaH. CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(-) and thereby promotes tumor growth. Cancer Cell2011; 19: 387–400
148.
YaeT, TsuchihashiK, IshimotoT, MotoharaT, YoshikawaM, YoshidaGJ, WadaT, MasukoT, MogushiK, TanakaH, OsawaT, KankiY, MinamiT, AburataniH, OhmuraM, KuboA, SuematsuM, TakahashiK, SayaH, NaganoO. Alternative splicing of CD44 mRNA by ESRP1 enhances lung colonization of metastatic cancer cell. Nat Commun2012; 3: 883
149.
IemataM, TakaradaT, HinoiE, TaniuraH, YonedaY. Suppression by glutamate of proliferative activity through glutathione depletion mediated by the cystine/glutamate antiporter in mesenchymal C3H10T1/2 stem cells. J Cell Physiol2007; 213: 721–9
Barroso-delJesusA, Romero-LopezC, Lucena-AguilarG, MelenGJ, SanchezL, LigeroG, Berzal-HerranzA, MenendezP. Embryonic stem cell-specific miR302-367 cluster: human gene structure and functional characterization of its core promoter. Mol Cell Biol2008; 28: 6609–19
152.
LinSL, ChangDC, Chang-LinS, LinCH, WuDT, ChenDT, YingSY. Mir-302 reprograms human skin cancer cells into a pluripotent ES-cell-like state. Rna2008; 14: 2115–24
153.
BourguignonLY, WongG, EarleC, ChenL. Hyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinoma. J Biol Chem2012; 287: 32800–24
154.
BaoW, FuHJ, XieQS, WangL, ZhangR, GuoZY, ZhaoJ, MengYL, RenXL, WangT, LiQ, JinBQ, YaoLB, WangRA, FanDM, ChenSY, JiaLT, YangAG. HER2 interacts with CD44 to up-regulate CXCR4 via epigenetic silencing of microRNA-139 in gastric cancer cells. Gastroenterology2011; 141: 2076–87 e2076
155.
ChengC, SharpPA. Regulation of CD44 alternative splicing by SRm160 and its potential role in tumor cell invasion. Mol Cell Biol2006; 26: 362–70
156.
MatterN, HerrlichP, KonigH. Signal-dependent regulation of splicing via phosphorylation of Sam68. Nature2002; 420: 691–5
157.
NaorD, SionovRV, Ish-ShalomD. CD44: structure, function, and association with the malignant process. Adv Cancer Res1997; 71: 241–319
158.
BourguignonLY, ZhuD, ZhuH. CD44 isoform-cytoskeleton interaction in oncogenic signaling and tumor progression. Front Biosci1998; 3: d637–649
159.
Orian-RousseauV, MorrisonH, MatzkeA, KastilanT, PaceG, HerrlichP, PontaH. Hepatocyte growth factor-induced Ras activation requires ERM proteins linked to both CD44v6 and F-actin. Mol Biol Cell2007; 18: 76–83
160.
TanikawaR, TanikawaT, HirashimaM, YamauchiA, TanakaY. Galectin-9 induces osteoblast differentiation through the CD44/Smad signaling pathway. Biochem Biophys Res Commun2010; 394: 317–22
La FleurL, JohanssonAC, RobergK. A CD44(high)/EGFR(low) subpopulation within head and neck cancer cell lines shows an epithelial-mesenchymal transition phenotype and resistance to treatment. PLoS One2012; 7: e44071
164.
TsatasD, KanagasundaramV, KayeA, NovakU. EGF receptor modifies cellular responses to hyaluronan in glioblastoma cell lines. J Clin Neurosci2002; 9: 282–8
BourguignonLY, ZhuH, ChuA, IidaN, ZhangL, HungMC. Interaction between the adhesion receptor, CD44, and the oncogene product, p185HER2, promotes human ovarian tumor cell activation. J Biol Chem1997; 272: 27913–18
167.
BourguignonLY, PeyrollierK, GiladE, BrightmanA. Hyaluronan-CD44 interaction with neural Wiskott-Aldrich syndrome protein (N-WASP) promotes actin polymerization and ErbB2 activation leading to beta-catenin nuclear translocation, transcriptional up-regulation, and cell migration in ovarian tumor cells. J Biol Chem2007; 282: 1265–80
168.
WakaharaK, KobayashiH, YagyuT, MatsuzakiH, KondoT, KuritaN, SekinoH, InagakiK, SuzukiM, KanayamaN, TeraoT. Bikunin down-regulates heterodimerization between CD44 and growth factor receptors and subsequently suppresses agonist-mediated signaling. J Cell Biochem2005; 94: 995–1009
169.
LevensteinME, LudwigTE, XuRH, LlanasRA, VanDenHeuvel-KramerK, ManningD, ThomsonJA. Basic fibroblast growth factor support of human embryonic stem cell self-renewal. Stem Cells2006; 24: 568–74
170.
AsosinghK, GunthertU, BakkusMH, De RaeveH, GoesE, Van RietI, Van CampB, VanderkerkenK. In vivo induction of insulin-like growth factor-I receptor and CD44v6 confers homing and adhesion to murine multiple myeloma cells. Cancer Res2000; 60: 3096–104
171.
LiC, WuJJ, HynesM, DoschJ, SarkarB, WellingTH, Pasca di MaglianoM, SimeoneDM. c-Met is a marker of pancreatic cancer stem cells and therapeutic target. Gastroenterology2011; 141: 2218–27e2215
172.
DammS, KoefingerP, StefanM, WelsC, MehesG, RichtigE, KerlH, OtteM, SchaiderH. HGF-promoted motility in primary human melanocytes depends on CD44v6 regulated via NF-kappa B, Egr-1, and C/EBP-beta. J Invest Dermatol2010; 130: 1893–903
173.
LiL, HeldinCH, HeldinP. Inhibition of platelet-derived growth factor-BB-induced receptor activation and fibroblast migration by hyaluronan activation of CD44. J Biol Chem2006; 281: 26512–19
174.
BourguignonLY, SingletonPA, ZhuH, ZhouB. Hyaluronan promotes signaling interaction between CD44 and the transforming growth factor beta receptor I in metastatic breast tumor cells. J Biol Chem2002; 277: 39703–12
YuQ, StamenkovicI. Transforming growth factor-beta facilitates breast carcinoma metastasis by promoting tumor cell survival. Clin Exp Metastasis2004; 21: 235–42
181.
MimaK, OkabeH, IshimotoT, HayashiH, NakagawaS, KurokiH, WatanabeM, BeppuT, TamadaM, NaganoO, SayaH, BabaH. CD44s regulates the TGF-beta-mediated mesenchymal phenotype and is associated with poor prognosis in patients with hepatocellular carcinoma. Cancer Res2012; 72: 3414–23
TremmelM, MatzkeA, AlbrechtI, LaibAM, OlakuV, Ballmer-HoferK, ChristoforiG, HeroultM, AugustinHG, PontaH, Orian-RousseauV. A CD44v6 peptide reveals a role of CD44 in VEGFR-2 signaling and angiogenesis. Blood2009; 114: 5236–44
184.
BarbourAP, ReederJA, WalshMD, FawcettJ, AntalisTM, GotleyDC. Expression of the CD44v2-10 isoform confers a metastatic phenotype: importance of the heparan sulfate attachment site CD44v3. Cancer Res2003; 63: 887–92
185.
ShermanL, WainwrightD, PontaH, HerrlichP. A splice variant of CD44 expressed in the apical ectodermal ridge presents fibroblast growth factors to limb mesenchyme and is required for limb outgrowth. Genes Dev1998; 12: 1058–71
186.
ZenK, LiuDQ, LiLM, ChenCX, GuoYL, HaB, ChenX, ZhangCY, LiuY. The heparan sulfate proteoglycan form of epithelial CD44v3 serves as a CD11b/CD18 counter-receptor during polymorphonuclear leukocyte transepithelial migration. J Biol Chem2009; 284: 3768–76
187.
KoppR, FichterM, SchalhornG, DanescuJ, ClassenS. Frequent expression of the high molecular, 673-bp CD44v3,v8-10 variant in colorectal adenomas and carcinomas. Int J Mol Med2009; 24: 677–83
188.
ZenK, LiuDQ, GuoYL, WangC, ShanJ, FangM, ZhangCY, LiuY. CD44v4 is a major E-selectin ligand that mediates breast cancer cell transendothelial migration. PLoS One2008; 3: e1826
189.
LocatelliA, LangeCA. Met receptors induce Sam68-dependent cell migration by activation of alternate extracellular signal-regulated kinase family members. J Biol Chem2011; 286: 21062–72
JijiwaM, DemirH, GuptaS, LeungC, JoshiK, OrozcoN, HuangT, YildizVO, ShibaharaI, de JesusJA, YongWH, MischelPS, FernandezS, KornblumHI, NakanoI. CD44v6 regulates growth of brain tumor stem cells partially through the AKT-mediated pathway. PLoS One2011; 6: e24217
193.
OhataH, IshiguroT, AiharaY, SatoA, SakaiH, SekineS, TaniguchiH, AkasuT, FujitaS, NakagamaH, OkamotoK. Induction of the stem-like cell regulator CD44 by Rho kinase inhibition contributes to the maintenance of colon cancer-initiating cells. Cancer Res2012; 72: 5101–10
194.
ChristO, GunthertU, HaasR, ZollerM. Importance of CD44v7 isoforms for homing and seeding of hematopoietic progenitor cells. J Leukoc Biol2001; 69: 343–52
195.
GhatakS, HascallVC, MarkwaldRR, MisraS. Stromal hyaluronan interaction with epithelial CD44 variants promotes prostate cancer invasiveness by augmenting expression and function of hepatocyte growth factor and androgen receptor. J Biol Chem2010; 285: 19821–32
196.
RoselM, KhaldoyanidiS, ZawadzkiV, ZollerM. Involvement of CD44 variant isoform v10 in progenitor cell adhesion and maturation. Exp Hematol1999; 27: 698–711
197.
ZoellerM. CD44v10 in hematopoiesis and stem cell mobilization. Leuk Lymphoma2000; 38: 463–80
